Never-frozen liquid plasma transfusion in civilian trauma: a nationwide propensity-matched analysis
Authors:
- 17 February 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
- Vol. 91 (1) , 200-205
Abstract
BACKGROUND: Never-frozen liquid plasma (LQP) was found to reduce component waste, decrease health care expenses, and have a superior hemostatic profile compared with fresh frozen plasma (FFP). Although transfusing LQP in hemorrhaging patients has become more common, its clinical effectiveness remains to be explored. This study aims to examine outcomes of trauma patients transfused with LQP compared with thawed FFP. METHODS: Adult (≥18 years) trauma patients receiving early (≤4 hours) plasma transfusions were identified in the Trauma Quality Improvement Program 2017. Patients were stratified into those receiving LQP versus FFP. Propensity-score matching in a 1:2 ratio was performed. Primary outcome measures were mortality and time to first plasma unit transfusion. Secondary outcome measures were major complications and hospital length of stay. RESULTS: A total of 107 adult trauma patients receiving LQP were matched to 214 patients receiving FFP. Mean age was 48 ± 19 years, 73% were male, and median Injury Severity Score was 27 [23–41]. A total of 42% of patients were in shock, 22% had penetrating injuries, and 31% required surgical intervention for hemorrhage control. Patients received a median of 4 [2–6] units of PRBC, 2 [1,3] units of LQP or FFP, and 1 [0–1] unit of platelets. The median time to the first LQP unit transfused was significantly shorter compared with the first FFP unit transfused (54 [28–79] minutes vs. 98 [59–133] minutes; p < 0.001). Rates of 24-hour mortality (2.8% vs. 3.7%; p = 0.664) and in-hospital mortality (16.8% vs. 20.1%; p = 0.481) were not different between the LQP and FFP groups. Similarly, there was no difference in major complications (15.9% vs. 21.5%; p = 0.233) and hospital length of stay (12 [6–21] vs. 12 [6–23] days; p = 0.826). CONCLUSION: Never-frozen liquid plasma is safe and effective in resuscitating trauma patients. Never-frozen liquid plasma has the potential to expand our transfusion armamentarium given its longer storage time and immediate availability. LEVEL OF EVIDENCE: Therapeutic, Level IV.Keywords
This publication has 17 references indexed in Scilit:
- Traumatic injury in the United States: In-patient epidemiology 2000–2011Injury, 2016
- The endothelial glycocalyx and its disruption, protection and regeneration: a narrative reviewScandinavian Journal of Trauma, Resuscitation and Emergency Medicine, 2016
- Plasma Resuscitation Promotes Coagulation Homeostasis Following Shock-Induced HypercoagulabilityShock, 2016
- Transfusion of Plasma, Platelets, and Red Blood Cells in a 1:1:1 vs a 1:1:2 Ratio and Mortality in Patients With Severe TraumaJAMA, 2015
- Never-frozen liquid plasma blocks endothelial permeability as effectively as thawed fresh frozen plasmaJournal of Trauma and Acute Care Surgery, 2014
- The Prospective, Observational, Multicenter, Major Trauma Transfusion (PROMMTT) StudyJAMA Surgery, 2013
- Better hemostatic profiles of never-frozen liquid plasma compared with thawed fresh frozen plasmaJournal of Trauma and Acute Care Surgery, 2013
- The impact of plasma preparations and their storage time on short-term posttransfusion mortality2012
- Plasma Restoration of Endothelial Glycocalyx in a Rodent Model of Hemorrhagic ShockAnesthesia & Analgesia, 2011
- Predefined Massive Transfusion Protocols are Associated With a Reduction in Organ Failure and Postinjury ComplicationsJournal of Trauma: Injury, Infection & Critical Care, 2009